This week's Fierce Pharma is brought to you by Clarivate.

Leading Innovators in Gene Editing

Gene editing is no longer just a dream—it’s a revolution in progress.

With the FDA’s approval of groundbreaking therapies like Casgevy and Lyfgenia, we’ve entered a new era. But the question remains: what’s next for this transformative field?

Our free resource delivers the inside scoop on:

• Under-the-radar startups rewriting the rules of gene editing
• Emerging targets and indications that promise to transform patient care
• Expert insights on overcoming clinical, regulatory, and IP challenges
• The ripple effect on regulators, payers, clinicians, and patients

Gene editing is reshaping medicine as we know it. Stay ahead of the curve with this free, expert-curated whitepaper. Innovation waits for no one. Be the first to know the trends driving the future of medicine.